Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 4
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 4, 2008
A 41-year-old man with polyarthritis and severe autonomic neuropathy
Matthew E Bourcier, Aaron I Vinik
Therapeutics and Clinical Risk Management 2008, 4:837-842
Published Date: 8 August 2008
The use of calcium and vitamin D in the management of osteoporosis
John A Sunyecz
Therapeutics and Clinical Risk Management 2008, 4:827-836
Published Date: 8 August 2008
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
Vincenzo Savica, Domenico Santoro, Paolo Monardo, Agostino Mallamace, Guido Bellinghieri
Therapeutics and Clinical Risk Management 2008, 4:821-826
Published Date: 8 August 2008
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki
Geoffrey S Dow, Alan J Magill, Colin Ohrt
Therapeutics and Clinical Risk Management 2008, 4:803-819
Published Date: 8 August 2008
The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
Hans Ludger Tillmann
Therapeutics and Clinical Risk Management 2008, 4:797-802
Published Date: 8 August 2008
Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
Ravinder Dhillon, Simona Rossi, Steven K Herrine
Therapeutics and Clinical Risk Management 2008, 4:789-796
Published Date: 8 August 2008
Review of oral oxymorphone in the management of pain
Paul Sloan
Therapeutics and Clinical Risk Management 2008, 4:777-787
Published Date: 8 August 2008
Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
Stephanie Hennigan, Arthur Kavanaugh
Therapeutics and Clinical Risk Management 2008, 4:767-775
Published Date: 8 August 2008
Combating HIV resistance – focus on darunavir
Cécile L Tremblay
Therapeutics and Clinical Risk Management 2008, 4:759-765
Published Date: 8 August 2008
Posaconazole in the management of refractory invasive fungal infections
Stefan Langner, Philipp B Staber, Peter Neumeister
Therapeutics and Clinical Risk Management 2008, 4:747-757
Published Date: 8 August 2008
Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
Sanford R Kimmel
Therapeutics and Clinical Risk Management 2008, 4:739-745
Published Date: 8 August 2008
Fospropofol disodium injection for the sedation of patients undergoing colonoscopy
Benjamin E Levitzky, John J Vargo
Therapeutics and Clinical Risk Management 2008, 4:733-738
Published Date: 8 August 2008
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin’s lymphoma
Rudolf Weide
Therapeutics and Clinical Risk Management 2008, 4:727-732
Published Date: 8 August 2008
Availability of a remote online hemodynamic monitoring system during treatment in a private dental office for medically high-risk patients
Shinya Yamazaki, Hiroyoshi Kawaai, Shigeo Sasaki, Kazuhiro Shimamura, Hiroshi Segawa, Takahiro Saito
Therapeutics and Clinical Risk Management 2008, 4:721-726
Published Date: 8 August 2008
Double-blind, randomized trial comparing efficacy and safety of continuing olanzapine versus switching to quetiapine in overweight or obese patients with schizophrenia or schizoaffective disorder
Walter Deberdt, Ilya Lipkovich, Alexandra N Heinloth, Lin Liu, Sara Kollack-Walker, et al
Therapeutics and Clinical Risk Management 2008, 4:713-720
Published Date: 8 August 2008
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria
Elmir Omerovic, Gerhard Brohall, Markus Müller, Truls Råmunddal, Göran Matejka, et al
Therapeutics and Clinical Risk Management 2008, 4:705-711
Published Date: 8 August 2008
Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitus
Lars Thomassen, Ulrike Waje-Andreassen, Halvor Naess
Therapeutics and Clinical Risk Management 2008, 4:699-703
Published Date: 8 August 2008
Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG
James E Skinner, Michael Meyer, William C Dalsey, Brian A Nester, George Ramalanjaona, et al
Therapeutics and Clinical Risk Management 2008, 4:689-697
Published Date: 8 August 2008
Postoperative mortality after inpatient surgery: Incidence and risk factors
Karamarie Fecho, Anne T Lunney, Philip G Boysen, Peter Rock, Edward A Norfleet
Therapeutics and Clinical Risk Management 2008, 4:681-688
Published Date: 8 August 2008
A systematic approach of tracking and reporting medication errors at a tertiary care university hospital, Karachi, Pakistan
Khurshid Khowaja, Rozmin Nizar, Rashida J Merchant, Jacqueline Dias, Irma Bustamante-Gavino, Amina Malik
Therapeutics and Clinical Risk Management 2008, 4:673-679
Published Date: 8 August 2008
Pain treatment with high-dose, controlled-release oxycodone: an Italian perspective
Fabio Ferrarese, Gioia Becchimanzi, Massimo Bernardo, Maria Anna Conte, Angela Gioia, et al
Therapeutics and Clinical Risk Management 2008, 4:665-671
Published Date: 8 August 2008